Latest News Archive
Please select Category, Year, and then Month to display items
03 January 2020
|
Story Xolisa Mnukwa
|
Photo Supplied
The UFS Bloemfontein Campus, South Campus, and Qwaqwa Campus choirs are student-centred choirs functioning under the Student Affairs’ Arts, Culture and Dialogue office.
It has been a noteworthy year for the University of the Free State (UFS) Choir, establishing itself on the student/university choir scene. The choir, based on the Bloemfontein Campus, represented the UFS at the bi-annual KUESTA choir festival earlier this year, showcasing its musical talent. The choir shared a stage with other university choirs from around the country.
The UFS (Bloemfontein Campus) Choir is a 42-member ensemble of students; the other two choirs, based on the South and Qwaqwa campuses, consist of 40 and 62 members respectively. The choirs are administered and managed by the Division of Student Affairs’ Arts, Culture and Dialogue Office. In addition to Kovsie culture, the choirs strive to have a varied repertoire of inclusive music, with the UFS BFN Campus choir performing a diversity of songs in English, Afrikaans, isiXhosa, and Sesotho.
The new South Campus choir was established in 2018 and is led by choir director, Bonisile Gcisa, who specialises in choral music. This leg of the choir will therefore perform many of his works, but will also include some of the Bloemfontein choir’s set lists, since most of the choir members will be auditioning in 2021 for the Bfn choir when they change campuses.
The Qwaqwa Campus choir will lean more towards a choral genre under the direction of Sipho Khumalo.
The UFS Bloemfontein Campus choir was officially re-established under the leadership of choir conductor Leona Geldenhuys in March 2018, and has performed at several events, including the Rector’s Concert, the annual KUESTA choir convention, and the Bloemfontein Choir invitational. The group has also held a number of public performances on the Thakaneng Bridge at the UFS Bloemfontein Campus.
“Part of the UFS Student Affairs’ objective is to create an inclusive and a socially just student lived experience, and that is the mandate the choirs will also adopt. We hope to create an experience that not only enhances our students’ singing abilities, but also contribute to a more inclusive university experience.” – Angelo Mockie – Director: UFS Student Affairs Arts, Culture and Dialogue office.
“Rest well, be safe, and return rejuvenated,” were his parting words to students for the festive season.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004